Loading…

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

Despite the applicability of histone deacetylase inhibitors (HDACis) for cancer treatment, several works in the literature have shown that these inhibitors can be used in several other diseases, such as neurodegenerative diseases (NDs). This review begins by discussing the signaling pathways of HDAC...

Full description

Saved in:
Bibliographic Details
Published in:Medicinal research reviews 2020-11, Vol.40 (6), p.2177-2211
Main Authors: Rodrigues, Daniel A., Pinheiro, Pedro de S. M., Sagrillo, Fernanda S., Bolognesi, Maria L., Fraga, Carlos A. M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite the applicability of histone deacetylase inhibitors (HDACis) for cancer treatment, several works in the literature have shown that these inhibitors can be used in several other diseases, such as neurodegenerative diseases (NDs). This review begins by discussing the signaling pathways of HDACs, focused on the context of NDs, presenting a discussion about the pharmacophoric features of HDACis and crystal structure analysis and discussing interesting case studies from the literature about the development of HDACis. Additionally, a discussion about the consequences of isoform‐selective inhibition vs pan‐HDACis on neurotoxic effects and clinical trial investigations of HDACis for NDs is also presented. Finally, we describe our perspective related to the future use of these inhibitors in the pharmacotherapy of NDs.
ISSN:0198-6325
1098-1128
DOI:10.1002/med.21701